CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system
Samia J. Khoury(Brigham and Women's Hospital), Wayne W. Hancock(Children's Hospital of Philadelphia), Mohamed H. Sayegh(American University of Beirut), Peter S. Linsley(Rosetta Stone (United States)), Enver Akalin(Brigham and Women's Hospital), Laurence A. Turka(Harvard University), Anil Chandraker(Brigham and Women's Hospital)
Cited by 202
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
|The Journal of Immunology|2001|953
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809